Ewha Womans University
Also known as: Ehwa Womans University Mokdong Hospital | Ehwa W. univ hospital | Ewah Womans University Medical Center | Ewha University Seoul Hospital | Ewha Womans University | Ewha Womans University College of Medicine | Ewha Womans University Dongdaemun Hospital | Ewha womans university hospital | Ewha Womans University Hospital | Ewha Womans University Medical Center of Korea | Ewha Womans University Mokdong | Ewha Womans University Mokdong Hospital | Ewha Womans University School of Medicine & Ewha Womans University Mokdong Hospital | Ewha Womans University Seoul hospital | Ewha Woman's University Seoul Hospital | Ewha Women's University Hospital | Ewha Women University Mokdong Hospital | Ewha W. University | I-wha Univ. | Iwha Womans Unversity | Iwha Womans Unversity Mokdong Hospital
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2005Last known activity
Mar 1, 2025
Timeline
1880s
- Jan 1, 1886
Ewha Womans University— Founded
Drugs by trial phase (74 distinct, 59 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (24 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Indications
Studied for
- Acalculous Cholecystitis
- Acute Kidney Injury
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Atrial Fibrillation
- Bipolar Disorder
- Bronchitis
- Cerebral Infarction
- Cholecystitis
- Cholecystitis, Acute
- Coronary Artery Disease
- Crohn Disease
- Depression
- Depressive Disorder
- Disease
- Dyspepsia
- Encephalitis
- Encephalitis, Japanese
- Endometriosis
- Epilepsy
- Erectile Dysfunction
- Essential Hypertension
- Gastritis
- Glomerulonephritis
- Heart Diseases
- Hepatitis
- Hepatitis B
- Hepatitis B, Chronic
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Infarction
- Infections
- Ischemia
- Ischemic Attack, Transient
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lower Urinary Tract Symptoms
- Lung Diseases
- Lung Diseases, Obstructive
- Major Depressive Disorder
- Myelodysplastic Syndromes
- Myocardial Infarction
- Myocardial Ischemia
- Osteoarthritis
- Premature Birth
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Tract Infections
- Spondylitis
- Spondylitis, Ankylosing
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Stroke
- Substance-Related Disorders
Recent trials (50)
- NCT06864052Sponsor investigatorN/AMar 1, 2025
- NCT06864052Lead sponsorN/AMar 1, 2025
- NCT06490328OfficialPhase 3May 30, 2024
- NCT06330038CollaboratorPhase 4May 1, 2024
- NCT05359224CollaboratorPhase 4Jun 13, 2022
- NCT04921189CollaboratorPhase 2Jun 4, 2021
- NCT05051332Overall official - principal investigatorPhase 3Mar 19, 2020
- NCT03993236CollaboratorPhase 4Jul 22, 2019
- NCT04014803CollaboratorPhase 4Jul 8, 2019
- NCT03576235CollaboratorN/AMay 1, 2018
- NCT03578055Reponsible party - principal investigatorPhase 3Apr 24, 2018
- NCT03578055Lead sponsorPhase 3Apr 24, 2018
- NCT03578055Overall official - principal investigatorPhase 3Apr 24, 2018
- NCT03357653Lead sponsorPhase 3Jan 30, 2018
- NCT03357653Overall official - principal investigatorPhase 3Jan 30, 2018
Details
- Founded
- Seoul, KR Jan 1, 1886
- Last known activity
- Mar 1, 2025